These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 12921323)
21. Stereotactic pallidotomy in a child with Hallervorden-Spatz disease. Case report. Justesen CR; Penn RD; Kroin JS; Egel RT J Neurosurg; 1999 Mar; 90(3):551-4. PubMed ID: 10067928 [TBL] [Abstract][Full Text] [Related]
22. Four siblings with Hallervorden-Spatz disease. Vaher U; Napa A; Nurmiste A; Piirsoo A; Sibul H; Talvik T Brain Dev; 2001 Jul; 23(4):236-9. PubMed ID: 11377002 [TBL] [Abstract][Full Text] [Related]
23. Hallervorden-Spatz syndrome in two siblings diagnosed by clinical features and magnetic resonance imaging. Tiamkao S; Nitinavakarn B; Jitpimolmard S J Med Assoc Thai; 2000 Dec; 83(12):1535-40. PubMed ID: 11253896 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathological study of familial late infantile Hallervorden-Spatz disease: a particular form of neuroacanthocytosis. Malandrini A; Fabrizi GM; Bartalucci P; Salvadori C; Berti G; Sabò C; Guazzi GC Childs Nerv Syst; 1996 Mar; 12(3):155-60. PubMed ID: 8697459 [TBL] [Abstract][Full Text] [Related]
25. [The role of magnetic resonance imaging in the diagnosis of Hallervorden-Spatz disease]. Tabuchi M; Mori E; Yamadori A Rinsho Shinkeigaku; 1990 Sep; 30(9):972-7. PubMed ID: 2265508 [TBL] [Abstract][Full Text] [Related]
26. Hallervorden-Spatz syndrome and MRI: the "tiger's eye". One case. Trussart V; Leboucq N; Carlander B; Billiard M; Castan P J Neuroradiol; 1993 Mar; 20(1):70-5. PubMed ID: 8492177 [TBL] [Abstract][Full Text] [Related]
32. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome. Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911 [TBL] [Abstract][Full Text] [Related]
33. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. Hayflick SJ; Hartman M; Coryell J; Gitschier J; Rowley H AJNR Am J Neuroradiol; 2006; 27(6):1230-3. PubMed ID: 16775270 [TBL] [Abstract][Full Text] [Related]
34. [Hallervorden-Spatz disease]. Ohno M; Goto I Nihon Rinsho; 1993 Nov; 51(11):2957-61. PubMed ID: 8277577 [TBL] [Abstract][Full Text] [Related]
35. [Neurodegeneration with brain iron accumulation, type-I (NBIA-I) (formerly Hallervorden-Spatz, disease). Par I: clinical manifestation and treatment]. Bertrand E Neurol Neurochir Pol; 2002; 36(5):947-58. PubMed ID: 12523119 [TBL] [Abstract][Full Text] [Related]
36. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Sethi KD; Adams RJ; Loring DW; el Gammal T Ann Neurol; 1988 Nov; 24(5):692-4. PubMed ID: 3202617 [TBL] [Abstract][Full Text] [Related]
37. [Contribution of nuclear magnetic imaging in the diagnosis of Hallervorden-Spatz syndrome]. Pedespan JM; Fontan D; Castell JF; Langlade P; Guillard JM Arch Fr Pediatr; 1993 Jan; 50(1):35-7. PubMed ID: 8507137 [TBL] [Abstract][Full Text] [Related]
38. Optic atrophy as the first symptom in Hallervorden-Spatz syndrome. Battistella PA; Midena E; Suppiej A; Carollo C Childs Nerv Syst; 1998 Mar; 14(3):135-8. PubMed ID: 9579871 [TBL] [Abstract][Full Text] [Related]